Purple Mild Holland Engages Graham Pechenik, Revered Patent and IP Lawyer and Editor-at-Giant of Psilocybin Alpha, as Senior Advisor to Advisory Board

red light holland logo

The Red Light Holland Corp. is pleased to announce that she has hired Graham Pechenik as a Senior Advisor to her advisory board. Graham is a registered patent attorney with degrees in biochemistry and cognitive neuroscience. Mr. Pechenik gained over a decade of experience representing Fortune 500 companies in the agricultural, chemical, pharmaceutical, biotech, and technology industries before joining Calyx Law in …

The Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland”) is pleased to announce that it has hired Graham Pechenik as Senior Advisor to its Advisory Board. Graham is a registered patent attorney with degrees in biochemistry and cognitive neuroscience. Mr. Pechenik gained over a decade of experience representing Fortune 500 companies in the agricultural, chemical, pharmaceutical, biotech, and technology industries before founding Calyx Law, the first intellectual property boutique specializing in cannabis and Psychedelics focused. Graham is also the Editor-in-Chief of Psilocybin Alpha, where he follows patent applications and writes on patent issues relating to psychedelics.

Graham Pechenik, a respected attorney who develops IP strategies, protects IP through patent and trademark registrations, and uses IP to generate value and growth, along with his strong support and advocacy of responsible psychedelics, joins Red Light Add The Dutch Advisory Board as Senior Advisor is another magical moment for the company, ”said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “Over the past seven months we’ve put together an incredible advisory board, including our Chairman Bruce Linton. Simply put, Graham was another desired piece of the puzzle that we were looking for to round out this very important and active team. We are delighted to have Graham a part of Red Light Holland, and our vision of education and information to ensure responsible, legal access to psilocybin aligns hugely. “

“After experiencing firsthand the benefits of psilocybin mushrooms and microdosing, including for anxiety, alcohol consumption, and alertness issues, I am a strong believer in using these benefits that I have personally seen (with no medical claims made) to make available to responsible adults everywhere, “said Graham Pechenik, founder of Calyx Law.” Even the discussion about the use of mushrooms is heavily stigmatized in most places. I look forward to the day when psilocybin mushrooms and – Hopefully truffles are more legally available and I am excited to help Red Light Holland raise awareness of the magic truffle around the world and it is an honor and pleasure to be working towards this vision with such an outstanding team.

In consideration of his duties as a Senior Advisor and subject to all applicable laws (including the rules and guidelines of the Canadian Stock Exchange) (“Applicable Laws”), the Company has granted Mr. Pechenik 250,000 stock incentive options (the “Options”). and individually the “Option”). Each option entitles the holder to purchase one common share in the capital of the Company for a period of three years from the date of issue at an exercise price of CND 0.315. The options are subject to applicable law and the terms of the Company’s stock option plan.

About Red Light Holland Corp.

The company is an Ontario-based company engaged in the production, growth and sale (via existing smart shop operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal leisure market in the Netherlands according to the highest standards in accordance with all applicable laws.

Further information about the company:

Todd Shapiro
Chief Executive Officer, Chairman and Director
Tel .: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Forward-Looking Statements

Neither the Canadian Stock Exchange nor its Market Regulator (as that term is defined in the Canadian Stock Exchange Policies) accepts responsibility for the adequacy or accuracy of this press release.

Certain information in this press release constitutes forward-looking statements within the meaning of applicable securities laws. All statements in this press release that are not historical facts may be considered forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potentially”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no guarantee that the plans, intentions or expectations for which they are set will be realized. Although management believes this information is reasonable at the time of preparation, it could prove to be incorrect and actual results could differ materially from those anticipated. The forward-looking statements contained in this press release speak as of the date of this press release, and the company undertakes no obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise, unless the relevant securities so require Legislation. Forward-looking statements in this press release are expressly qualified by this cautionary statement.

Not for redistribution on Newswire services in the United States or for distribution in the United States.

The source version of this press release can be found at https://www.newsfilecorp.com/release/71218